FGF 21 A biomarker composition for diagnosing or prognosising thyroid cancer comprising FGF 21

摘要

The present invention relates to a biomarker composition for diagnosis of thyroid cancer or prediction of thyroid cancer prognosis containing FGF 21, a composition for diagnosis of thyroid cancer or prediction of thyroid cancer prognosis using the same, a kit, a method for providing information for diagnosis of thyroid cancer or prediction of thyroid cancer prognosis, and a method for diagnosis of thyroid cancer or prediction of thyroid cancer prognosis. FGF21 of the present invention is overexpressed in patients with thyroid cancer, and FGF 21 is a factor deeply related to cell growth, cell migration, and cell invasion of thyroid cancer cells. Therefore, the FGF21 can diagnose thyroid cancer when used as a biomarker, and can also accurately predict the prognosis of patients with thyroid cancer, making it useful for related pharmaceutical and medical businesses.